March 11, 2011
A federal judge in Delaware sided with Watson Pharmaceuticals Inc. on Friday in a lawsuit Cephalon Inc. lodged over its efforts to market a generic version of the painkiller Fentora, finding two of three asserted patents for the drug were invalid.